Skip to content
1887
Preview this article:

There is no abstract available.

Loading

Article metrics loading...

/content/journal/jmm/10.1099/jmm.0.000075
2015-07-01
2025-11-10

Metrics

Loading full text...

Full text loading...

References

  1. De Francesco V., Margiotta M., Zullo A., Hassan C., Troiani L., Burattini O., Stella F., Di Leo A., Russo F., other authors. 2006a; Clarithromycin-resistant genotypes and eradication of Helicobacter pylori . Ann Intern Med 144:94–100 [CrossRef]
    [Google Scholar]
  2. De Francesco V., Margiotta M., Zullo A., Hassan C., Valle N.D., Burattini O., Cea U., Stoppino G., Amoruso A., other authors. 2006b; Primary clarithromycin resistance in Italy assessed on Helicobacter pylori DNA sequences by TaqMan real-time polymerase chain reaction. Aliment Pharmacol Ther 23:429–435 [View Article][PubMed]
    [Google Scholar]
  3. De Francesco V., Zullo A., Ierardi E., Giorgio F., Perna F., Hassan C., Panella C., Vaira D. 2009a; The A2143G point mutation of clarithromycin resistance affects Helicobacter pylori eradication. J Clin Gastroenterol 43:386 [View Article][PubMed]
    [Google Scholar]
  4. De Francesco V., Zullo A., Ierardi E., Vaira D. 2009b; Minimal inhibitory concentration (MIC) values and different point mutations in the 23S rRNA gene for clarithromycin resistance in Helicobacter pylori . Dig Liver Dis 41:610–611 [View Article][PubMed]
    [Google Scholar]
  5. De Francesco V., Giorgio F., Ierardi E., Zotti M., Neri M., Milano A., Varasano V., Luzza F., Suraci E., other authors. 2011; Primary clarithromycin resistance in Helicobacter pylori: the Multicentric Italian Clarithromycin Resistance Observational (MICRO) study. J Gastrointestin Liver Dis 20:235–239[PubMed]
    [Google Scholar]
  6. Ierardi E., Giorgio F., Losurdo G., Di Leo A., Principi M. 2013; How antibiotic resistances could change Helicobacter pylori treatment: a matter of geography?. World J Gastroenterol 19:8168–8180 [View Article][PubMed]
    [Google Scholar]
  7. Ierardi E., Goni E., Losurdo G., Di Mario F. 2014; Helicobacter pylori and nonmalignant diseases. Helicobacter 19:(Suppl. 1)27–31 [View Article][PubMed]
    [Google Scholar]
  8. Landis J.R., Koch G.G. 1977; The measurement of observer agreement for categorical data. Biometrics 33:159–174 [View Article][PubMed]
    [Google Scholar]
  9. Malfertheiner P., Megraud F., O'Morain C.A., Atherton J., Axon A.T., Bazzoli F., Gensini G.F., Gisbert J.P., Graham D.Y., other authors. 2012; Management of Helicobacter pylori infection – the Maastricht IV/Florence Consensus Report. Gut 61:646–664 [View Article][PubMed]
    [Google Scholar]
  10. Monno R., Giorgio F., Carmine P., Soleo L., Cinquepalmi V., Ierardi E. 2012; Helicobacter pylori clarithromycin resistance detected by Etest and TaqMan real-time polymerase chain reaction: a comparative study. APMIS 120:712–717 [View Article][PubMed]
    [Google Scholar]
  11. Patel S.K., Pratap C.B., Jain A.K., Gulati A.K., Nath G. 2014; Diagnosis of Helicobacter pylori: what should be the gold standard?. World J Gastroenterol 20:12847–12859 [View Article][PubMed]
    [Google Scholar]
  12. Ricci C., Holton J., Vaira D. 2007; Diagnosis of Helicobacter pylori: invasive and non-invasive tests. Best Pract Res Clin Gastroenterol 21:299–313 [View Article][PubMed]
    [Google Scholar]
  13. Schulz K.F., Grimes D.A. 2005; Sample size calculations in randomised trials: mandatory and mystical. Lancet 365:1348–1353 [View Article][PubMed]
    [Google Scholar]
/content/journal/jmm/10.1099/jmm.0.000075
Loading
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An error occurred
Approval was partially successful, following selected items could not be processed due to error